Evropska unija - slovenščina - EMA (European Medicines Agency)

serb sa - amifampridine phosphate - lambert-eaton myasthenic syndrome; paraneoplastic syndromes, nervous system; nervous system neoplasms; paraneoplastic syndromes; nervous system diseases; autoimmune diseases of the nervous system; neurodegenerative diseases; neuromuscular diseases; neuromuscular junction diseases; immune system diseases; autoimmune diseases; autoimmune diseases of the nervous system; cancer; neoplasms - druga zdravila na živčnem sistemu - simptomatsko zdravljenje lambert-eaton miastenični sindrom (lotile) pri odraslih.

Evropska unija - slovenščina - EMA (European Medicines Agency)

serb sa - amifampridin - lambert-eaton miastenični sindrom - druga zdravila na živčnem sistemu - simptomatsko zdravljenje lambert-eaton miastenični sindrom (lotile) pri odraslih.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

biomarin europe ltd. - amifampridin - tableta - amifampridin 10 mg / 1 tableta - amifampridin

Evropska unija - slovenščina - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir natrij, rilpivirine hidroklorid - okužbe z virusom hiv - antivirusi za sistemsko uporabo - juluca je primerna za zdravljenje virusom humane imunske pomanjkljivosti tipa 1 (hiv-1) okužbe pri odraslih, ki so virologically-zatreti (hiv-1 rna.

Evropska unija - slovenščina - EMA (European Medicines Agency)

viiv healthcare bv - dolutegravir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Evropska unija - slovenščina - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - okužbe z virusom hiv - antivirusi za sistemsko uporabo - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Evropska unija - slovenščina - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir natrij, lamivudine - okužbe z virusom hiv - antivirusi za sistemsko uporabo - dovato je primerna za zdravljenje virusom humane imunske pomanjkljivosti tipa 1 (hiv-1) okužbe v odrasli in mladostniki nad 12 let starosti, ki tehta najmanj 40 kg, z ni znano, ali obstaja sum, odpornost na integrase zaviralec razred, ali lamivudine.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

3,4-diaminopiridin - peroralni prašek - 3,4-diaminopiridin 20 mg / 1 prašek - amifampridin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

3,4-diaminopiridin - peroralni prašek - 3,4-diaminopiridin 1 mg / 1 prašek - amifampridin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

3,4-diaminopiridin - peroralni prašek - 3,4-diaminopiridin 10 mg / 1 prašek - amifampridin